Cargando…
Associations of Drug Lipophilicity and Extent of Metabolism with Drug-Induced Liver Injury
Drug-induced liver injury (DILI), although rare, is a frequent cause of adverse drug reactions resulting in warnings and withdrawals of numerous medications. Despite the research community’s best efforts, current testing strategies aimed at identifying hepatotoxic drugs prior to human trials are not...
Autores principales: | McEuen, Kristin, Borlak, Jürgen, Tong, Weida, Chen, Minjun |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5535828/ https://www.ncbi.nlm.nih.gov/pubmed/28640208 http://dx.doi.org/10.3390/ijms18071335 |
Ejemplares similares
-
Drug-Induced Liver Injury
por: Almario, Eileen E. N., et al.
Publicado: (2017) -
Mechanistically linked serum miRNAs distinguish between drug induced and fatty liver disease of different grades
por: Liu, Zhichao, et al.
Publicado: (2016) -
Development of Decision Forest Models for Prediction of Drug-Induced Liver Injury in Humans Using A Large Set of FDA-approved Drugs
por: Hong, Huixiao, et al.
Publicado: (2017) -
BERT-Based Natural Language Processing of Drug Labeling Documents: A Case Study for Classifying Drug-Induced Liver Injury Risk
por: Wu, Yue, et al.
Publicado: (2021) -
Deciphering miRNA transcription factor feed-forward loops to identify drug repurposing candidates for cystic fibrosis
por: Liu, Zhichao, et al.
Publicado: (2014)